Can individual fatty acids be used as functional biomarkers of dairy fat consumption in relation to cardiometabolic health? A narrative review—CORRIGENDUM

Keywords: Corrigendum
Details of correction: reformatted Table 2 supplied

 Existing text: 

See Table 2


Table: Table 2.

Prospective human studies investigating the associations between circulating levels of odd-chain or trans
Table: -fatty acids and incident CVD, CVD mortality or incident type 2 diabetes (T2D)

C15:0, pentadecanoic acid; C17:0, heptadecanoic acid; tPA, trans-palmitoleic acid; M, male; F, female; y, year; T2D, type 2 diabetes; IH, intracerebral haemorrhage; SH, subarachnoid haemorrhage; Apo, apolipoprotein; FA, fatty acids; PA, physical activity; ↑, direct association; ↓, inverse association; ↔, no association.

*HR and OR presented as estimate (95 % confidence interval).


 

 Corrected text should read: 

See updated and reformatted Table 2


Table: Table 2.

Prospective human studies investigating the associations between circulating levels of odd-chain or trans
Table: -fatty acids and incident CVD, CVD mortality or incident type 2 diabetes (T2D)

C15:0, pentadecanoic acid; C17:0, heptadecanoic acid; tPA, trans-palmitoleic acid; M, male; F, female; y, year; T2D, type 2 diabetes; IH, intracerebral haemorrhage; SH, subarachnoid haemorrhage; Apo, apolipoprotein; FA, fatty acids; PA, physical activity; ↑, direct association; ↓, inverse association; ↔, no association.

*HR and OR presented as estimate (95 % confidence interval).
Sellem Laury, Jackson Kim G., Paper Laura, Givens Ian D., Lovegrove Julie A.
Can individual fatty acids be used as functional biomarkers of dairy fat consumption in relation to cardiometabolic health? A narrative review—CORRIGENDUM